These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 6602461
1. Complexes of Cl-inhibitor (Cl-INH) and hemostatic enzymes in normal plasma. Donaldson VH, Harrison RR. Adv Exp Med Biol; 1983; 156():149-55. PubMed ID: 6602461 [No Abstract] [Full Text] [Related]
2. Structural and functional characterization of factor XII. Tans G, Rosing J. Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074 [Abstract] [Full Text] [Related]
6. The biochemistry and pathophysiology of the contact system of plasma. Cochrane CG, Griffin JH. Adv Immunol; 1982 Jan; 33():241-306. PubMed ID: 6182767 [No Abstract] [Full Text] [Related]
7. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay. Kaplan AP, Gruber B, Harpel PC. Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374 [Abstract] [Full Text] [Related]
8. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets. Rao AK, Schmaier AH, Colman RW. Pathobiol Annu; 1982 Sep; 12():35-64. PubMed ID: 6186978 [No Abstract] [Full Text] [Related]
10. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation. Donaldson VH, Harrison RA. Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203 [No Abstract] [Full Text] [Related]
11. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions. Colman RW, Schmaier AH. Crit Rev Oncol Hematol; 1986 Jul; 5(1):57-85. PubMed ID: 3633772 [Abstract] [Full Text] [Related]
14. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. Liu CY, Scott CF, Bagdasarian A, Pierce JV, Kaplan AP, Colman RW. J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091 [Abstract] [Full Text] [Related]
16. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays. Nuijens JH, Huijbregts CC, Cohen M, Navis GO, de Vries A, Eerenberg AJ, Bakker JC, Hack CE. Thromb Haemost; 1987 Aug 04; 58(2):778-85. PubMed ID: 2445044 [Abstract] [Full Text] [Related]
17. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJ, Curd JG, Colman RW. N Engl J Med; 1983 May 05; 308(18):1050-3. PubMed ID: 6601240 [Abstract] [Full Text] [Related]
18. Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies. Akiyama H, Sinha D, Seaman FS, Kirby EP, Walsh PN. J Clin Invest; 1986 Dec 05; 78(6):1631-7. PubMed ID: 3491093 [Abstract] [Full Text] [Related]
20. Regulation of the coagulant activity and surface binding of high molecular weight kininogen. Colman RW, Silver LD, Purdon AD, Chang JJ, Scott CF. Trans Assoc Am Physicians; 1984 Dec 05; 97():113-23. PubMed ID: 6336014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]